文献速递主动脉疾病

现成器械治疗胸主动脉疾病:烟囱或医生自制开窗TEVAR的中期随访

Off-the-Shelf Devices for Treatment of Thoracic Aortic Diseases: Midterm Follow-up of TEVAR With Chimneys or Physician-Made Fenestrations.
PubMed 文献 · J Endovasc Ther · 2019-12-02

该回顾性研究分析了2008至2016年474例接受烟囱TEVAR(ch-TEVAR,n=364)或台上自制开窗TEVAR(f-TEVAR,n=110)治疗胸主动脉夹层或动脉瘤的患者。围手术期技术成功率100%,30天死亡率0.8%,中期随访(平均50.6个月)主动脉相关死亡率2.3%。f-TEVAR组分支闭塞免除率(92%)显著高于ch-TEVAR组(83%,p=0.007),开窗TEVAR短期和中期结局似乎更有利。

要点

  • 现成烟囱和自制开窗TEVAR治疗累及弓上分支的胸主动脉疾病均可行,再干预率低。
  • f-TEVAR组分支闭塞免除率92%,显著优于ch-TEVAR组的83%(p=0.007)。
  • ch-TEVAR组术中I型内漏和随访期I型内漏发生率均显著高于f-TEVAR组(p<0.01)。

核心结论

  • 采用烟囱移植物和自制开窗的现成技术均是治疗累及弓上分支的胸主动脉夹层和动脉瘤的合适选择,再干预发生率低。
  • 开窗TEVAR似乎具有更有利的短期和中期结局,值得进一步研究用于主动脉弓修复。

研究设计与样本

  • 回顾性分析2008至2016年连续474例患者(平均年龄62.3±10.7岁,346例男性),接受f-TEVAR(n=110)或ch-TEVAR(n=364)。
  • 病变包括352例胸主动脉夹层(f-TEVAR 81例,ch-TEVAR 271例)和122例胸主动脉瘤(f-TEVAR 29例,ch-TEVAR 93例)。

主要发现

  • 术中I型内漏处理69例(14.6%),其中f-TEVAR 4例、ch-TEVAR 65例(p<0.01),技术成功率100%。
  • 30天内死亡4例(0.8%),f-TEVAR 1例(0.9%)、ch-TEVAR 3例(0.8%);围手术期脑缺血9例(1.9%),其中1例致命性卒中。
  • 平均随访50.6±20.0个月期间,主动脉相关事件死亡11例(2.3%);I型内漏40例(8.4%),f-TEVAR 1例、ch-TEVAR 39例(p<0.01)。
  • 支架移植物移位11例(2.3%),逆行性夹层13例(2.7%);593枚分支支架中闭塞100枚(16.9%),f-TEVAR组4/75、ch-TEVAR组96/518(p<0.01)。
  • 分支再干预率7.2%(34/474);f-TEVAR组分支闭塞免除概率(92%)显著高于ch-TEVAR组(83%,p=0.007)。

临床怎么用

  • 对于累及弓上分支的胸主动脉夹层或动脉瘤,可考虑使用烟囱或自制开窗TEVAR现成技术。
  • 开窗TEVAR在分支通畅性和内漏方面可能更具优势,选择术式时可结合解剖条件和中心经验权衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose: To evaluate the midterm outcomes of thoracic endovascular aortic repair (TEVAR) using chimney grafts (ch-TEVAR) or thoracic stent-grafts with fenestrations made on the back table (f-TEVAR) to treat thoracic aortic dissection (TAD) and thoracic aortic aneurysm (TAA). Materials and Methods: A retrospective analysis was conducted of 474 consecutive patients (mean age 62.3±10.7 years; 346 men) treated with either f-TEVAR (n=110) or ch-TEVAR (n=364) for 352 TADs (81 f-TEVAR and 271 ch-TEVAR) or 122 TAAs (29 f-TEVAR and 93 ch-TEVAR) from 2008 to 2016. The primary endpoints at 30 days and during follow-up were overall mortality, aorta-related mortality, and major complications. The secondary endpoints were endoleak and reintervention. The patency of the target branches, cost of hospitalization, and the use of antiplatelet drugs were also analyzed. Results: Intraoperative type I endoleaks were treated in 69 (14.6%) cases (4 f-TEVAR and 65 ch-TEVAR, p<0.01) to achieve 100% technical success. Four (0.8%) patients died within 30 days [1 (0.9%) f-TEVAR and 3 (0.8%) ch-TEVAR]. Perioperative cerebral ischemia (1 fatal stroke) occurred in 9 (1.9%) patients: (1 f-TEVAR and 8 ch-TEVAR, p=0.39). During the mean follow-up of 50.6±20.0 months (49.5±18.3 months in f-TEVAR and 50.9±20.6 months in ch-TEVAR), 11 (2.3%) patients died of an aorta-related event. Type I endoleak was present in 40 (8.4%) patients (1 f-TEVAR and 39 ch-TEVAR, p<0.01). Eleven (2.3%) patients experienced stent-graft migration and 13 (2.7%) had a retrograde dissection. One hundred (16.9%) of the 593 branch stents occluded (4/75 in the f-TEVAR group and 96/518 in the ch-TEVAR group, p<0.01). The branch reintervention rate was 7.2% (34/474). The f-TEVAR group had a significantly higher probability of freedom from branch occlusion (92%) than the ch-TEVAR group (83%, p=0.007). Conclusion: Off-the-shelf techniques employing chimney grafts and homemade fenestrations are both suitable options for TAD and TAA involving the supra-aortic branches, with a low incidence of reintervention. Fenestrated TEVAR seems to have more favorable short- and midterm outcomes. Further study of these off-the-shelf techniques for aortic arch repair is warranted.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Zhang L, Wu MT, Zhu GL, et al. Off-the-Shelf Devices for Treatment of Thoracic Aortic Diseases: Midterm Follow-up of TEVAR With Chimneys or Physician-Made Fenestrations. J Endovasc Ther. 2019. PMID: 31789078. doi:10.1177/1526602819890107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。